Skip to main content
SpringerLink
Log in

Physicochemical Principles of Controlled Release Veterinary Pharmaceuticals

  • Chapter
  • First Online:
Long Acting Animal Health Drug Products

Part of the book series: Advances in Delivery Science and Technology ((ADST))

  • 1549 Accesses

Abstract

This chapter describes the basic physical and chemical properties ­relevant to drug formulation. It encompasses discussion on the active pharmaceutical ingredient, excipients, and final product and it highlights the importance of physical and chemical attributes of compounds in the selection of ingredients; development of dosage forms; and its significance in active and product assessment, characterization, performance, and quality.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Florence AT, Attwood D (2011) Solids. In: Physicochemical principles of pharmacy, 5th edn. Pharmaceutical Press, London, pp 7–42

    Google Scholar 

  2. Mullin JW (2001) Crystallization, 4th edn. Butterworth-Heinemann, Oxford, Boston

    Google Scholar 

  3. Buckton G (2007) Solid-state properties. In: Aulton ME (ed) Aulton’s pharmaceutics, 3rd edn. Churchill Livingston Elsevier, Philadelphia, pp 110–120

    Google Scholar 

  4. Yu L (2001) Amorphous pharmaceutical solids: preparation, characterization and stabilization. Adv Drug Deliv Rev 48:27–42

    CAS  Google Scholar 

  5. Morissette SL, Almarsson Ö, Peterson ML, Remenar JF, Read MJ, Lemmo AV, Ellis S, Cima MJ, Gardner CR (2004) High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. Adv Drug Deliv Rev 56:275–300

    CAS  Google Scholar 

  6. Duddu SP, Zhang G, Dal Monte PR (1997) The relationship between protein aggregation and molecular mobility below the glass transition temperature of lyophilized formulations containing a monoclonal antibody. Pharm Res 14:596–600

    CAS  Google Scholar 

  7. Hancock BC, Zografi G (1997) Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci 86:1–12

    CAS  Google Scholar 

  8. Marín ML, López J, Sánchez A, Vilaplana J, Jiménez A (1998) Analysis of potentially toxic phthalate plasticizers used in toy manufacturing. Bull Environ Contam Toxicol 60:68–73

    Google Scholar 

  9. Hancock BC, Zografi G (1997) The relationship between the glass transition temperature and the water content of amorphous pharmaceutical solids. Pharm Res 11:471–477

    Google Scholar 

  10. Ashford M (2007) Gastrointestinal tract-physiology and drug absorption. In: Aulton ME (ed) Aulton’s pharmaceutics, 3rd edn. Churchill Livingston Elsevier, Philadelphia, pp 270–285

    Google Scholar 

  11. Kahn CM, Line S (eds) (2010) The Merck veterinary manual, 10th edn. Merck Publishing Group, Rahway

    Google Scholar 

  12. Noyes AA, Whitney WR (1897) The rate of solution of solid substances in their own solutions. J Am Chem Soc 19:930–934

    Google Scholar 

  13. Brunner E (1904) Reaktionsgeschwindigkeit in Heterogenen Systemen. Z Phys Chem 43:56–102

    Google Scholar 

  14. Nernst W (1904) Theorie der Reaktionsgeschwindigkeit in Heterogenen Systemen. Z Phys Chem 47:52–55

    CAS  Google Scholar 

  15. Aulton ME (2007) Dissolution and solubility. In: Aulton ME (ed) Aulton’s pharmaceutics, 3rd edn. Churchill Livingston Elsevier, Philadelphia, pp 16–32

    Google Scholar 

  16. Rowe RC, Sheskey PJ, Quinn ME (eds) (2009) Handbook of pharmaceutical excipients. Pharmaceutical Press, London

    Google Scholar 

  17. Taylor MD (1996) Improved passive oral drug delivery via prodrugs. Adv Drug Deliv Rev 19:131–148

    CAS  Google Scholar 

  18. Loftsson T, Brewster ME (1996) Pharmaceutical applications of cyclodextrins. 1. Drug ­solubilization and stabilization. J Pharm Sci 85:1017–1025

    CAS  Google Scholar 

  19. Kwon GS (2003) Polymeric micelles for delivery of poorly water-soluble compounds. Crit Rev Ther Drug 20:357–403

    CAS  Google Scholar 

  20. Staniforth JN, Aulton ME (2007) Particle size analysis. In: Aulton ME (ed) Aulton’s pharmaceutics, 3rd edn. Churchill Livingston Elsevier, Philadelphia, pp 121–136

    Google Scholar 

  21. Carr RL (1965) Evaluating flow properties of solids. Chem Eng 72:163–168

    CAS  Google Scholar 

  22. Summers MP, Aulton ME (2007) Granulation. In: Aulton ME (ed) Aulton’s pharmaceutics, 3rd edn. Churchill Livingston Elsevier, Philadelphia, pp 410–423

    Google Scholar 

  23. Rhodes MJ (2008) Introduction to particle technology, 2nd edn. Wiley, Hoboken, NJ

    Google Scholar 

  24. Staniforth JN, Aulton ME (2007) Particle Size Reduction. In: Aulton ME (ed) Aulton’s pharmaceutics, 3rd edn. Churchill Livingston Elsevier, Philadelphia, pp 137–144

    Google Scholar 

  25. Mosharraf M, Nystrom C (2003) Apparent solubility of drugs in partially crystalline systems. Drug Dev Ind Pharm 29:603–622

    CAS  Google Scholar 

  26. Florence AT, Attwood D (2011) The solubility of drugs. In: Physicochemical principles of pharmacy, 5th edn. Pharmaceutical Press, London, pp 141–183

    Google Scholar 

  27. Po HN, Senozan NM (2001) The Henderson–Hasselbalch equation: its history and limitations. J Chem Educ 78:1499–1503

    CAS  Google Scholar 

  28. Aulton ME (2007) Properties of solutions. In: Aulton ME (ed) Aulton’s pharmaceutics, 3rd edn. Churchill Livingston Elsevier, Philadelphia, pp 33–41

    Google Scholar 

  29. Constable PD (2009) Comparative animal physiology and adaption. In: Kellum JA, Elbers PWG (eds) Stewart’s textbook of acid-base. Lulu, Raleigh, pp 305–320

    Google Scholar 

  30. Avdeef A (2003) Absorption and drug development: solubility, permeability and charge state. Wiley, Hoboken, NJ

    Google Scholar 

  31. Leo AJ, Hansch C, Elkins D (1971) Partition coefficients and their uses. Chem Rev 71:525–616

    CAS  Google Scholar 

  32. Leahy DE, Taylor PJ, Wait AR (1989) Model solvent systems for QSAR Part I. Propylene glycol dipelargonate (PGDP). A new standard solvent for use in partition coefficient determination. Quant Struct Act Relat 8:17–31

    CAS  Google Scholar 

  33. Leahy DE, Morris JJ, Taylor PJ (1992) Model solvent systems for QSAR. Part II. Fragment values (f-values) for the critical quartet. J Chem Soc Perkin Trans 2:705–722

    Google Scholar 

  34. Rosenkranz H, Förster D (1979) Comparative study of the binding of acylureidopenicillins and carbenicillin to human serum proteins. Infection 7:102–108

    CAS  Google Scholar 

  35. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3–26

    CAS  Google Scholar 

  36. Bear J (1972) Dynamics of fluids in porous media. Dover Publications Inc, New York

    Google Scholar 

  37. Lieberman NP, Lieberman ET (2003) A working guide to process equipment. McGraw-Hill, New York, pp 449–453

    Google Scholar 

  38. McKennell R (1956) Cone-plate viscometer. Anal Chem 28:1710–1714

    CAS  Google Scholar 

  39. Lyklema J (2005) Fundamentals of interface and colloid science: particulate colloids (Fundamentals of interface & colloid science). Academic Press, Waltham

    Google Scholar 

  40. Florence AT, Attwood D (2011) Emulsions, suspensions and other disperse systems. In: Physicochemical principles of pharmacy, 5th edn. Pharmaceutical Press, London, pp 241–280

    Google Scholar 

  41. University of the Sciences in Philadelphia (2011) Remington: the science and practice of pharmacy, 21st edn. Pharmaceutical Press, London

    Google Scholar 

  42. The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (2003) ICH topic Q1A stability testing of new drug substances and products. Available from http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q1A_R2/Step4/Q1A_R2__Guideline_OnlinePDF.pdf

  43. The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (1995) ICH topic Q5C stability testing of biotechnological/biological products. Available from http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q5C/Step4/Q5C_Guideline_OnlinePDF.pdf

  44. International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Products (2008) VICH GL3(R) stability testing of new drug substances and medicinal products (revision). Available from http://www.vichsec.org/pdf/2007/GL03_ST7(R)_OnlinePDF.pdf.

  45. Brown WH, Foote CS, Iverson BL, Anslyn EV (2010) Organic chemistry: enhanced, 5th edn. Cengage Learning Inc, Stamford

    Google Scholar 

  46. Gaginella TS, Bertko RJ, Kachur JF (1987) Effect of dextromethorphan and levomethorphan on gastric emptying and intestinal transit in the rat. J Pharmacol Exp Ther 240:388–391

    CAS  Google Scholar 

  47. Reddy IK, Mehvar R (2004) Chirality in drug design and development. Marcel Dekker, New York

    Google Scholar 

  48. Medicines and Healthcare products Regulatory Agency (MHRA) (2007) Phthalates/DEHP in PVC medical devices. Available from http://www.mhra.gov.uk/Safetyinformation/General safetyinformationandadvice/Technicalinformation/PhthalatesinPVCmedicaldevices/index.htm

  49. Murphy KP (2001) Stabilization of protein structure. In: Murphy KP (ed) Protein structure, stability, and folding. Humana Press Inc, Totowa

    Google Scholar 

  50. European Pharmacopoeia (2010) Section 5.2 parenteral preparations, 7th edn. EDQM Publications, Strasbourg, pp 3144–3146

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Pharmacy and Chemistry, Kingston University, Kingston upon Thames, UK

    John G. Fletcher & Raid G. Alany

  2. Division of Pharmacy, International Medical University, Kuala Lumpur, Malaysia

    Michael J. Rathbone

Authors
  1. John G. Fletcher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael J. Rathbone
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Raid G. Alany
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John G. Fletcher .

Editor information

Editors and Affiliations

  1. Division of Pharmacy, International Medical University, #126 Jalan Jalil Perkasa 19, Bukit Jalil, Kuala Lumpur, 57000, Malaysia

    Michael J. Rathbone

  2. , New Zealand's National School of Pharmac, University of Otago, Dunedin, 9054, New Zealand

    Arlene McDowell

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Controlled Release Society

About this chapter

Cite this chapter

Fletcher, J.G., Rathbone, M.J., Alany, R.G. (2013). Physicochemical Principles of Controlled Release Veterinary Pharmaceuticals. In: Rathbone, M., McDowell, A. (eds) Long Acting Animal Health Drug Products. Advances in Delivery Science and Technology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4439-8_5

Download citation

Publish with us

Policies and ethics

Search

Navigation